---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-004539"
form_type: "8-K"
ticker: "PALI"
cik: "0001357459"
company_name: "PALISADE BIO, INC."
filed_at: "2024-02-01T23:59:59+00:00"
generated_at: "2026-06-06T10:50:15.375510+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Palisade Bio exercises warrants for $2.5M gross proceeds; exercise price reduced to $0.7313

## Summary
- Exercise of ~3.4M Existing Warrants at reduced price of $0.7313 per share, raising ~$2.5M gross.
- Replacement Warrants issued for each exercised warrant, exercisable at $0.7313 for 5 years.
- Existing warrants initially had exercise prices up to $35.525/share; investors received new warrants.
- Ladenburg Thalmann acted as placement agent, earning 7.75% cash fee and 6% warrant coverage.
- Net proceeds to be used for working capital and general corporate purposes.

## SEC filing metadata
- accession: 0001493152-24-004539
- form_type: 8-K
- ticker: PALI
- cik: 0001357459
- company_name: PALISADE BIO, INC.
- filed_at: 2024-02-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1357459/000149315224004539/0001493152-24-004539-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1357459/000149315224004539/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-004539
- JSON: https://secwatch.observer/filing/0001493152-24-004539.json
- Plain text: https://secwatch.observer/filing/0001493152-24-004539.txt

## Key facts
- Material Agreements
  PALISADE BIO, INC. entered into warrant inducement agreements with certain accredited and institutional holders valued at approximately $2,502,717 (effective 2024-01-30).
  - Action: entry
  - Counterparty: certain accredited and institutional holders
  - Value: approximately $2,502,717
  - Effective: 2024-01-30
  source text: On January 30, 2024, Palisade Bio, Inc. (the “Company”) entered into warrant inducement agreements (the “Agreements”) with certain accredited and institutional holders (collectively, the “Holders”)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1357459/000149315224004539/0001493152-24-004539-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.